The press-pulse therapeutic strategy first 'presses' — restricts glucose via ketogenic diet and fasting to starve the tumour and reduce its aggressiveness. Then it 'pulses' — delivers drugs targeting glutamine to kill the now-weakened cancer cells, particularly the metastatic hybrids. Low-dose chemo and immunotherapy then finish off what remains, attacking the tumour at its weakest.